Statement Of Financial Position [Abstract]

Biotest AG - Filing #6464577

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Property, plant and equipment
5,149,000,000 EUR
5,224,000,000 EUR
Right-of-use assets
559,000,000 EUR
560,000,000 EUR
Deferred tax assets
195,000,000 EUR
329,000,000 EUR
Cash and cash equivalents
1,078,000,000 EUR
1,081,000,000 EUR
1,166,000,000 EUR
Assets
1,434,000 EUR
1,410,900 EUR
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
396,000,000 EUR
396,000,000 EUR
Retained earnings
2,745,000,000 EUR
2,498,000,000 EUR
Share premium
2,198,000,000 EUR
2,198,000,000 EUR
Other reserves
32,000,000 EUR
103,000,000 EUR
Equity attributable to owners of parent
5,307,000,000 EUR
4,989,000,000 EUR
Equity
2,745,000,000 EUR
2,198,000,000 EUR
5,307,000,000 EUR
396,000,000 EUR
53,000,000 EUR
85,000,000 EUR
2,198,000,000 EUR
396,000,000 EUR
11,000,000 EUR
115,000,000 EUR
2,498,000,000 EUR
4,989,000,000 EUR
3,711,000,000 EUR
1,232,000,000 EUR
396,000,000 EUR
20,000,000 EUR
2,198,000,000 EUR
95,000,000 EUR
Liabilities [abstract]
Deferred tax liabilities
11,000,000 EUR
11,000,000 EUR
Liabilities
9,033,000,000 EUR
9,120,000,000 EUR
Equity and liabilities
1,434,000 EUR
1,410,900 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.